Followers | 128 |
Posts | 2150 |
Boards Moderated | 1 |
Alias Born | 12/27/2007 |
Friday, January 13, 2017 11:18:51 AM
Very attractive and unknown FDA play with HUGE upside Potential i see thefair value around $20 per share .GL
NEOS Therapeutics (NEOS)
Market Cap: $91 M
Cash: $60 M
Price $5.90
Shares Out: 16.06 M
Presentation
http://investors.neostx.com/phoenix.zhtml?c=254075&p=irol-presentations
•Adzenys XR-ODT launched May, 2016
•Robust prescription growth since launch
•22,797 total TRx through December 2, 2016
•Pipeline includes two late-stage product candidates for the treatment of ADHD
•Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016
•Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM